High expression of PODXL has been linked to poor prognosis in a wide range of malignancies including gastrointestinal adenocarcinomas such as colorectal cancer [14–16], pancreatic and periampullary cancer [17–20] and gastric cancer [21]. Here, PODXL is linked to colorectal cancer.